Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dutton - Strong Speculative Buy

ROSEVILLE, Calif.--(BUSINESS WIRE)--Dutton Associates continues coverage of Patriot Scientific (OTCBB:PTSC - News), raising its rating to Strong Speculative Buy and a price target at $.55. The 15-page report by Dutton senior analyst Richard W. West, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks, Reuters, Knobias, and other leading financial portals



Since our February 7, 2008 Update Research Report, Patriot Scientific announced changes in management. After the resignation of James Turley, Rick Goerner was appointed as Interim Chief Executive Officer and Interim President. From 2002 through 2006, Goerner served as President and Chief Executive Officer of Transdimension Inc., an Irvine, California-based, venture-financed, technology company providing embedded universal serial bus (USB) silicon and software solutions. In addition, Donald Schrock, formerly of Qualcomm CDMA Technologies Group until his retirement in 2003, was appointed to Patriot Scientifics Board of Directors. This management team is aggressively pursuing an acquisition program to bring in an operating company to Patriot Scientific. Since January 2006 through February 29, 2008, TPL Group has granted 44 licenses resulting in recognized revenue of $219.7 million to Phoenix Digital Solutions. Patriot Scientifics share in that revenue since January 2006 was $92.8 million. Since January 2008, the pace of patent license sales has accelerated and, more importantly, the recent sales were to major well known, recognizable names. Taking advantage of attractive price-point opportunities, Patriot Scientific announced a resumption of the Companys open market share repurchase program. Patriot Scientific is debt-free, with a strong cash-heavy balance sheet. We feel comfortable with this new management team and look forward to the execution of the aggressive merger and acquisition strategy.

Share
New Message
Please login to post a reply